Clinical Trial Update: Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol [Phase 3]

View source ↗

Summary

Phase 3 trial update for inclisiran in participants with atherosclerotic cardiovascular disease and elevated LDL cholesterol has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Elevated Cholesterol

Drugs mentioned

• Inclisiran (inclisiran)

Snippet

Sponsor: The Medicines Company | Conditions: ASCVD, Elevated Cholesterol | Phase 3 | Status: COMPLETED | Results posted: 2020-10-05